Tag: licensing
-
Drug Discovery Company Lands Venture Funds, Licensing Deal
Vascular Pharmaceuticals Inc., a drug discovery company in Chapel Hill, North Carolina, secured $16 million in series A funds, the first round of financing after start-up. The company, a developer of drugs to treat complications of diabetes, also signed a licensing agreement for its lead compound with Janssen Biotech, a division of Johnson & Johnson.…
-
Nanotech Process Devised for Graphene Semiconductors
Researchers at the Norwegian University of Science and Technology in Trondheim developed a process to make semiconductors by growing nanoscale wires on a graphene substrate. Helge Weman (pictured left), a professor of electronics, led the research team that published its findings last month in the journal Nano Letters; paid subscription required. Weman also co-founded a…
-
New Materials Developed with Vast Surface Areas
Materials scientists and engineers at Northwestern University in Evanston, Illinois and University of Surrey in the U.K. created two new synthetic materials with the largest reported amounts of internal surface area. The researchers published their findings online in the Journal of the American Chemical Society (paid subscription required). The two new materials, known as NU-109…
-
National Lab Licenses Neutron Detector for Life Sciences
Oak Ridge National Laboratory in Tennessee licensed one of its technologies for detecting neutrons to PartTec Ltd. in Bloomington, Indiana that develops neutron detectors and related systems. Financial aspects of the agreement were not disclosed. The licensed technology — called the Neutron-Sensitive Anger Camera — allows researchers to study a range of crystalline structures for…
-
Early-Stage Biomedical Accelerator Gains $21M Initial Funding
BioMotiv, a Cleveland company supporting early-stage medical research for commercial development into therapies, secured $21 million in its first financing round. The funds are being provided by BioMotiv’s founding investors, University Hospitals health care system in northeast Ohio and the Harrington Family of Hudson, Ohio, a supporter of translational biomedical research. The company provides financing…
-
Janssen Licenses Biotech’s Antibody for Multiple Myeloma
Janssen Pharmaceutical Companies, a division of Johnson & Johnson in Horsham, Pennsylvania, agreed to license a cancer drug targeting multiple myeloma made by biotechnology company Genmab A/S in Copenhagen, Denmark. The agreement has a total potential value of $1.1 billion from upfront, milestone, and royalty payments, as well as an equity investment in Genmab. The…
-
New Process Simplifies Protein Production for Drug Companies
A chemical engineer at University of Arkansas in Fayetteville developed a new method for producing high quality proteins used in drugs for treating an assortment of disorders. Doctoral candidate Ellen Brune (pictured right) also founded a company, Boston Mountain Biotech, to commercialize the technology. Current industry methods for protein manufacturing require separating out the background…
-
Biopharm, Monsanto to Partner on Agricultural Biotechnology
Alnylam Pharmaceuticals Inc. in Cambridge, Massachusetts and Monsanto Company in St. Louis, will collaborate on developing biotechnology applications in agriculture. The agreement has an immediate value to Alnylam of $29.2 million. The 10-year agreement gives Monsanto exclusive rights worldwide to use Alnylam’s platform technology and intellectual property in the field of agriculture. Alnylam is a…
-
National Lab, Software Company Form Text Analysis Subsidiary
Oak Ridge National Lab in Tennessee formed a subsidiary with Professional Project Services (Pro2Serve), an engineering company in Oak Ridge, to provide text analysis services using software developed at the lab. The software, known as Piranha, performs high-volume document analysis for military and security users. Financial terms of the deal were not disclosed. Piranha analyzes…
-
Biotech Begins Clinical Trial for Stroke Treatment
ZZ Biotech, a biotechnology company in Houston, began a clinical trial of an experimental drug to treat acute ischemic stroke, where blood flow to the brain is blocked by a clot. The drug being tested is 3K3A-APC, the result of research first conducted at University of Southern California and Scripps Research Institute in California, and…